Constructing narratives of heroism and villainy: case study of Myriads BRACAnalysis® compared to Genentechs Herceptin®

摘要

BackgroundThe development of Herceptin^® is welcomed as a major advance in breast cancer treatment, while Myriad's development of BRACAnalysis^® is a widely used diagnostic. However useful and successful this product is, its presence in the public eye is tainted by predominantly negative press about gene patenting and business practices.